Environmental factors such as low temperatures and carbon monoxide levels in the air have long been underestimated as risk factors for triggering a heart attack, new research suggests.
Social deprivation, infectious diseases, broken bones, and even poison apples: The life of Disney princesses is fraught with hidden health risks, a new study reveals.
Analyses of self-tests for human papillomavirus (HPV) can be used to divide HPV-positive women into three risk groups, according to a new study. This could enhance cervical cancer screening.
The Covid-19 pandemic was handled very differently across European healthcare systems. To better prepare for future crises, scientific experts from 13 European countries reviewed key lessons learned.
New study results could help detect whether a newborn baby with fever has sepsis or another serious bacterial infection, without the need for invasive testing.
A new way to inhibit the proliferation of Sars-CoV-2 opens up new perspectives in the fight against this coronavirus and other viral diseases that still have no medical treatment.
The current rise in antibiotic resistance is once again sparking interest in phage therapy. Now, scientists developed a new tool that recommends the best possible phage cocktail for a given patient.
Two studies indicate warning signs about spread of bacteria resistant to the same group of antibiotics (carbapenems) in both healthcare and community settings across Europe.
New research has shown that using artificial intelligence (AI) can improve how urinary tract infections (UTIs) are treated, and help to address antimicrobial resistance (AMR).
Wastewater treatment fails to kill several human pathogens, such as Listeria or E. coli, when they hide out on microplastics in the water, according to a new study.
New technology shows promise in protecting an implant against infections from resistant bacteria: By heating up small nanorods of gold with near-infrared light (NIR), the bacteria are killed.
Rsearchers developed a novel bioelectronic device that taps into the natural electrical activity of certain bacteria found on our skin, paving the way for a drug-free approach to managing infections.
People who have been fully vaccinated against Covid-19 have a significantly lower risk of developing more severe cardiovascular conditions linked to Covid-19 infection, a new study shows.
Many aspects of long Covid are still poorly understood, so many sufferers have turned to self-monitoring via wearables. New research explores the benefits and drawbacks of this approach.
While awareness for antimicrobial resistance (AMR) in bacteria is relatively high, fungal pathogens remain largely ignored – a blind spot with potentially dire consequences for global health.
Immunocompromised patients are at greatest risk of developing severe Covid-19 after an infection. While early antiviral treatments yield best results, even late-onset therapies still show benefits.
Protection from established Covid-19 vaccines wanes relatively quickly. A new vector vaccine elicits prolonged immune response in animal models, and maintains its efficacy over extended time.
Researchers have developed an artificial intelligence which can differentiate cancer cells from normal cells, as well as detect the very early stages of viral infection inside cells.
Infections caused by antibiotic-resistant (AMR) bacteria are a major issue in hospitals. A new technique aims to effectively track all types of relevant microorganisms simultaneously.
Infections caused by both IVs and catheters occur in 10% of patients. However, up to a quarter are not necessary. New research shows how to reduce this use and, thus, infections.
Toxoplasma gondii is a parasite with the ability to infect the brain, causing life-threatening diseases. Researchers now want to harness its properties to advance treatment of cognitive disorders.
Researchers have developed a fluorescence assay for viral integrity (or FAIRY, for short), to quickly determine the effectiveness of countermeasures against a given virus.
Klebsiella is among the top three pathogens responsible for hospital-acquired infections (HAIs). Now, researchers discovered why the bacteria thrive in clinical environments.
New research reveals a promising approach to developing a universal influenza vaccine that confers lifetime immunity against an evolving virus considered most likely to trigger the next pandemic.
Staphylococcus aureus is a leading cause of hospital-acquired bacterial infection, associated with over one million deaths worldwide each year. Now, researchers could be one step closer to a vaccine.
